ESSA Pharma (EPIX) Competitors

Cryoport (NASDAQ:CYRX) and ESSA Pharma (NASDAQ:EPIX) are both small-cap transportation companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, dividends, community ranking, analyst recommendations, risk, institutional ownership, earnings, media sentiment and valuation.

Which has more volatility and risk, CYRX or EPIX?

Cryoport has a beta of 1.81, indicating that its stock price is 81% more volatile than the S&P 500. Comparatively, ESSA Pharma has a beta of 1.61, indicating that its stock price is 61% more volatile than the S&P 500.

Does the media refer more to CYRX or EPIX?

In the previous week, Cryoport had 11 more articles in the media than ESSA Pharma. MarketBeat recorded 12 mentions for Cryoport and 1 mentions for ESSA Pharma. Cryoport's average media sentiment score of 0.75 beat ESSA Pharma's score of 0.16 indicating that Cryoport is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cryoport	2 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
ESSA Pharma	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Does the MarketBeat Community prefer CYRX or EPIX?

ESSA Pharma received 98 more outperform votes than Cryoport when rated by MarketBeat users. Likewise, 75.87% of users gave ESSA Pharma an outperform vote while only 65.88% of users gave Cryoport an outperform vote.

Company	Underperform	Outperform
Cryoport	Outperform Votes 251 65.88%	Underperform Votes 130 34.12%
ESSA Pharma	Outperform Votes 349 75.87%	Underperform Votes 111 24.13%

Do insiders & institutionals believe in CYRX or EPIX?

92.9% of Cryoport shares are held by institutional investors. Comparatively, 75.1% of ESSA Pharma shares are held by institutional investors. 10.1% of Cryoport shares are held by insiders. Comparatively, 15.5% of ESSA Pharma shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Is CYRX or EPIX more profitable?

ESSA Pharma has a net margin of 0.00% compared to Cryoport's net margin of -70.08%. Cryoport's return on equity of -13.35% beat ESSA Pharma's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cryoport	-70.08%	-13.35%	-6.43%
ESSA Pharma	N/A	-24.61%	-23.87%

Do analysts rate CYRX or EPIX?

Cryoport currently has a consensus target price of $11.67, suggesting a potential upside of 110.21%. ESSA Pharma has a consensus target price of $9.50, suggesting a potential upside of 430.73%. Given ESSA Pharma's higher possible upside, analysts plainly believe ESSA Pharma is more favorable than Cryoport.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cryoport	0 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.83
ESSA Pharma	0 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Which has stronger earnings and valuation, CYRX or EPIX?

ESSA Pharma has lower revenue, but higher earnings than Cryoport. ESSA Pharma is trading at a lower price-to-earnings ratio than Cryoport, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cryoport	$228.39M	1.21	-$99.59M	-$2.49	-2.23
ESSA Pharma	N/A	N/A	-$28.54M	-$0.69	-2.59

Summary

Cryoport beats ESSA Pharma on 10 of the 17 factors compared between the two stocks.